Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioRise is a Brazilian biotechnology company specializing in regenerative medicine and advanced cell-based therapies. The company focuses on the development and application of mesenchymal stem cells (MSCs) for both human and veterinary health, targeting conditions with high unmet medical needs such as osteoarthritis and complex wound healing. BioRise operates a specialized laboratory for cell processing and has established a commercial presence in the veterinary market with its Bio-Cell product line. Their R&D efforts leverage the immunomodulatory and regenerative properties of stem cells to promote tissue repair and reduce inflammation in orthopedic and neurological indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biorise.